US 6,586,227 B2 · Non-virulent Porphyromonas gingivalis mutant

Abstract

The Porphyromonas gingivalis strain which is deposited at ATCC under accession number 202109. A pharmaceutical composition comprising the Porphyromonas gingivalis strain of the present invention.

Claims2

Dependent claims

The Porphyromonas gingivalis strain which is deposited at ATCC under accession number 202109.

Dependencies are inferred from the claim text.

Facts

Application

09/803,766Filed 12 Mar 2001 · division

Priority

12 Aug 1998

Published

US 2001/0012512 A19 Aug 2001

Granted

1 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 39/0216
Bacterial antigens: bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
A61P 1/02
Drugs for disorders of the alimentary tract or the digestive system: stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
C07K 14/195
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from bacteria

Abstract

The Porphyromonas gingivalis strain which is deposited at ATCC under accession number 202109. A pharmaceutical composition comprising the Porphyromonas gingivalis strain of the present invention.

Non-virulent Porphyromonas gingivalis mutant

Life of this patent

Abstract

Claims2

Non-virulent Porphyromonas gingivalis mutant

Life of this patent

Abstract

Claims2